Structural basis for the action of the drug trametinib at KSR-bound MEKZ.M. Khan, Arvin C. Dar, Alexander M. Real et al.|Nature|2020Cited by 172
WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinomaAlexander Rialdi, Arvin C. Dar, Frank Fonseca et al.|Nature Cancer|2023Cited by 27
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC PolypharmacologyJia Xin Yu, Arvin C. Dar, Amanda J. Craig et al.|Molecular Cancer Therapeutics|2019Cited by 21
Abstract PR05: A novel kinase inhibitor for B-catenin mutant hepatocellular carcinomaAlexander Rialdi, Ernesto Guccione, Mary E. Duffy et al.|Clinical Cancer Research|2022Cited by 0